ClinicalTrials.Veeva

Menu

Caffeine for Preterm Infants With Apnea of Prematurity(AOP)

A

Army Medical University of People's Liberation Army

Status

Unknown

Conditions

Caffeine
Apnea of Prematurity

Treatments

Drug: 20mg/kg of caffeine
Drug: 80mg/kg of caffeine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Nowadays,caffein is commonly used for AOP, and it reduces the intubation rate in preterm infants. However, intubation is needed in about 20%-50% of partial neonates. How to reduce the intubation rate effectively is a challenge for neonatologists.

Full description

Less evidences about more dose of caffein used in preterm infants.

Enrollment

100 estimated patients

Sex

All

Ages

1 minute to 1 month old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • gestational age less than 32 weeks;
  • appear AOP;
  • parents'consents are obtained.

Exclusion criteria

  • major congenital abnormalities;
  • Parents' rejection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups

80mg/kg of caffeine
Experimental group
Description:
80mg/kg of caffeine is given to treat AOP.
Treatment:
Drug: 80mg/kg of caffeine
20mg/kg of caffeine
Active Comparator group
Description:
20mg/kg of caffeine is given to treat AOP.
Treatment:
Drug: 20mg/kg of caffeine

Trial contacts and locations

1

Loading...

Central trial contact

Shi Yuan, MD;PhD; Ma Juan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems